Canada markets closed

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.7600-0.0210 (-2.69%)
At close: 04:00PM EDT
0.7600 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 31.54M
Enterprise Value -95.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.22
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-8.43%
S&P500 52-Week Change 322.36%
52 Week High 31.7600
52 Week Low 30.7400
50-Day Moving Average 31.1006
200-Day Moving Average 30.9528

Share Statistics

Avg Vol (3 month) 3765.2k
Avg Vol (10 day) 3226.59k
Shares Outstanding 541.5M
Implied Shares Outstanding 641.5M
Float 821.21M
% Held by Insiders 16.71%
% Held by Institutions 150.86%
Shares Short (Apr 15, 2024) 437.83k
Short Ratio (Apr 15, 2024) 40.1
Short % of Float (Apr 15, 2024) 40.15%
Short % of Shares Outstanding (Apr 15, 2024) 40.09%
Shares Short (prior month Mar 15, 2024) 468.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.61%
Return on Equity (ttm)-41.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -70.44M
Net Income Avi to Common (ttm)-69.67M
Diluted EPS (ttm)-1.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)131.54M
Total Cash Per Share (mrq)3.2
Total Debt (mrq)4.62M
Total Debt/Equity (mrq)3.24%
Current Ratio (mrq)8.57
Book Value Per Share (mrq)3.46

Cash Flow Statement

Operating Cash Flow (ttm)-48.45M
Levered Free Cash Flow (ttm)-28.2M